Company intelligence / Profile preview

ESMS Global

London, Greater London, UKesmsglobal.com ↗

Ownership: Private
Employees: ~49
Development stage: Other

Overview

ESMS Global provides 24/7 medical monitoring, emergency unblinding, and medical information services to support clinical trials and marketed products globally. The company specializes in patient safety during all trial stages and post-marketing surveillance. It supports over 300 studies with more than 110K patients in 80 countries across 45+ languages. Its expertise helps prevent unnecessary unblindings and ensures rapid response to medical emergencies during trials.

Industry: Contract Research Organization

Partnerships

Almac Group – partnership for integrated emergency unblinding/IRT solutions for clinical trialsQVigilance – preferred partnership agreement for pharmacovigilance and risk management integration with MI services

Beyond the preview

Go deeper on ESMS Global.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ESMS Global.

Explore the full profile